Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant montelukast sodium and levocetirizine dihydrochloride in perennial allergic rhinitis
KCT0000484Phase 3Recruiting
- Sponsor
- Hanmi Pharmaceutical
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of montelukast, levocetirizine in perennial rhinitis, sponsored by Hanmi Pharmaceutical. Started Jun 2012; status: recruiting.
02
Drugs
montelukastlevocetirizine
03
Conditions
perennial rhinitis
Beyond the preview
Go deeper on KCT0000484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000484.